Investment Type: Venture Capital
Mentions in press and media 1
Date | Title | Description | Source |
18.02.2014 | Novimmune announces closing of CHF 60 million financing | Jonathan Hepple, Partner at Rosetta, has joined Novimmune's Board of Directors. Hepple brings more... | startuptic... |